Marc Ballas is MOMA’s SVP, Head of Clinical Development. He joined the company in 2024 and will oversee the company’s clinical function, with initial focus on the development of MOMA’s two lead precision oncology assets as they progress into the clinic in the near term. Dr. Ballas joins from Novocure where he most recently served as the Global Head of Clinical Development & Operations, overseeing the team accountable for full protocol design, management and delivery processes. Prior to Novocure, he held senior-level clinical roles at GSK, AstraZeneca and BMS.
Dr. Ballas holds an M.P.H. from Columbia University and received his M.D. from Albert Einstein College of Medicine of Yeshiva University. He completed his residency in Internal Medicine at Montefiore Medical Center and his fellowship in Oncology Hematology with the National Institutes of Health.